Literature DB >> 11032734

Formic acid dissolves aggregates of an N-terminal huntingtin fragment containing an expanded polyglutamine tract: applying to quantification of protein components of the aggregates.

N Hazeki1, T Tukamoto, J Goto, I Kanazawa.   

Abstract

Huntington's disease (HD) is caused by an expansion of the CAG repeat that encodes polyglutamine in huntingtin. Transient expression of an N-terminal huntingtin fragment containing an expanded polyglutamine tract induced formation of protein aggregates in cultured cells. The turnover of protein components in such aggregates has been difficult to study because of their insolubility in aqueous solutions. Here we describe a method of solubilizing the aggregates and quantifying their protein components. Insoluble pellets were collected from COS7 cells expressing an N-terminal huntingtin fragment containing an expanded polyglutamine tract and subjected to treatment with various detergent, acid, and alkaline reagents. Treatment with 100% formic acid at 37 degrees C for 30 min induced essentially complete dissociation of the aggregates to monomer. We used this solubilization technique to quantify huntingtin fusion protein in the aggregates formed in transient expression experiments. The frequency of aggregate formation increased when the proteasome inhibitor beta-lactone was added to culture media. However, the total amount of accumulated huntingtin fusion protein did not differ between cells cultured with or without beta-lactone. These results suggest that other protein components which are degraded by the proteasome, in addition to huntingtin, might be related to the dynamics of polyglutamine protein aggregates. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11032734     DOI: 10.1006/bbrc.2000.3682

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  34 in total

Review 1.  Protein aggregates and dementia: is there a common toxicity?

Authors:  S Lovestone; D M McLoughlin
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-02       Impact factor: 10.154

2.  Targeting expression of expanded polyglutamine proteins to the endoplasmic reticulum or mitochondria prevents their aggregation.

Authors:  Erwann Rousseau; Benjamin Dehay; Léa Ben-Haïem; Yvon Trottier; Michel Morange; Anne Bertolotti
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

3.  Inhibition of Aggregation of Mutant Huntingtin by Nucleic Acid Aptamers In Vitro and in a Yeast Model of Huntington's Disease.

Authors:  Rajeev K Chaudhary; Kinjal A Patel; Milan K Patel; Radha H Joshi; Ipsita Roy
Journal:  Mol Ther       Date:  2015-08-27       Impact factor: 11.454

4.  Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation.

Authors:  Atsushi Iwata; John C Christianson; Mirella Bucci; Lisa M Ellerby; Nobuyuki Nukina; Lysia S Forno; Ron R Kopito
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-02       Impact factor: 11.205

5.  Chapter 3: A fluorescent window into protein folding and aggregation in cells.

Authors:  Zoya Ignatova; Lila M Gierasch
Journal:  Methods Cell Biol       Date:  2008       Impact factor: 1.441

6.  Irreversible aggregation of protein synthesis machinery after focal brain ischemia.

Authors:  F Zhang; C L Liu; B R Hu
Journal:  J Neurochem       Date:  2006-07       Impact factor: 5.372

Review 7.  Aggregation of expanded huntingtin in the brains of patients with Huntington disease.

Authors:  Guylaine Hoffner; Sylvie Souès; Philippe Djian
Journal:  Prion       Date:  2007 Jan-Mar       Impact factor: 3.931

8.  Neuroprotective effects of calmodulin peptide 76-121aa: disruption of calmodulin binding to mutant huntingtin.

Authors:  Nichole L Dudek; Ying Dai; Nancy A Muma
Journal:  Brain Pathol       Date:  2009-03-10       Impact factor: 6.508

9.  Phosphorylation of threonine 3: implications for Huntingtin aggregation and neurotoxicity.

Authors:  Charity T Aiken; Joan S Steffan; Cortnie M Guerrero; Hasan Khashwji; Tamas Lukacsovich; Danielle Simmons; Judy M Purcell; Kimia Menhaji; Ya-Zhen Zhu; Kim Green; Frank Laferla; Lan Huang; Leslie Michels Thompson; J Lawrence Marsh
Journal:  J Biol Chem       Date:  2009-08-26       Impact factor: 5.157

10.  The carboxy-terminal fragment of alpha(1A) calcium channel preferentially aggregates in the cytoplasm of human spinocerebellar ataxia type 6 Purkinje cells.

Authors:  Taro Ishiguro; Kinya Ishikawa; Makoto Takahashi; Masato Obayashi; Takeshi Amino; Nozomu Sato; Masaki Sakamoto; Hiroto Fujigasaki; Fuminori Tsuruta; Ricardo Dolmetsch; Takao Arai; Hidenao Sasaki; Kazuro Nagashima; Takeo Kato; Mitsunori Yamada; Hitoshi Takahashi; Yoshio Hashizume; Hidehiro Mizusawa
Journal:  Acta Neuropathol       Date:  2009-12-31       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.